Format
Sort by
Items per page

Send to

Choose Destination

Links from MedGen

Items: 1 to 20 of 500

1.

Behavioral features in young adults with FG syndrome (Opitz-Kaveggia syndrome).

Graham JM Jr, Clark RD, Moeschler JB, Rogers RC.

Am J Med Genet C Semin Med Genet. 2010 Nov 15;154C(4):477-85. doi: 10.1002/ajmg.c.30284. Review.

2.

A novel mutation in MED12 causes FG syndrome (Opitz-Kaveggia syndrome).

Rump P, Niessen RC, Verbruggen KT, Brouwer OF, de Raad M, Hordijk R.

Clin Genet. 2011 Feb;79(2):183-8. doi: 10.1111/j.1399-0004.2010.01449.x.

PMID:
20507344
3.

Behavior of 10 patients with FG syndrome (Opitz-Kaveggia syndrome) and the p.R961W mutation in the MED12 gene.

Graham JM Jr, Visootsak J, Dykens E, Huddleston L, Clark RD, Jones KL, Moeschler JB, Opitz JM, Morford J, Simensen R, Rogers RC, Schwartz CE, Friez MJ, Stevenson RE.

Am J Med Genet A. 2008 Dec 1;146A(23):3011-7. doi: 10.1002/ajmg.a.32553.

4.

A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome.

Risheg H, Graham JM Jr, Clark RD, Rogers RC, Opitz JM, Moeschler JB, Peiffer AP, May M, Joseph SM, Jones JR, Stevenson RE, Schwartz CE, Friez MJ.

Nat Genet. 2007 Apr;39(4):451-3. Epub 2007 Mar 4.

PMID:
17334363
5.

FDA OKs Abemaciclib for ER+, HER2- Breast Cancer.

[No authors listed]

Cancer Discov. 2017 Nov;7(11):OF1. doi: 10.1158/2159-8290.CD-NB2017-141. Epub 2017 Oct 4.

PMID:
28978559
6.

Panel OKs CAR T Therapy for Leukemia.

[No authors listed]

Cancer Discov. 2017 Sep;7(9):924. doi: 10.1158/2159-8290.CD-NB2017-108. Epub 2017 Jul 27.

PMID:
28751490
7.

Responsiveness of the Knee Injury and Osteoarthritis Outcome Score (KOOS) and the Oxford Knee Score (OKS) in Japanese patients with high tibial osteotomy.

Goldhahn S, Takeuchi R, Nakamura N, Nakamura R, Sawaguchi T.

J Orthop Sci. 2017 Sep;22(5):862-867. doi: 10.1016/j.jos.2017.04.013. Epub 2017 Jun 7.

PMID:
28599878
8.

Congress OKs $2 Billion Boost for the NIH.

[No authors listed]

Cancer Discov. 2017 Jul;7(7):657. doi: 10.1158/2159-8290.CD-NB2017-069. Epub 2017 May 18.

PMID:
28522683
9.

A de novo splice site mutation in CASK causes FG syndrome-4 and congenital nystagmus.

Dunn P, Prigatano GP, Szelinger S, Roth J, Siniard AL, Claasen AM, Richholt RF, De Both M, Corneveaux JJ, Moskowitz AM, Balak C, Piras IS, Russell M, Courtright AL, Belnap N, Rangasamy S, Ramsey K, Opitz JM, Craig DW, Narayanan V, Huentelman MJ, Schrauwen I.

Am J Med Genet A. 2017 Mar;173(3):611-617. doi: 10.1002/ajmg.a.38069. Epub 2017 Jan 31.

PMID:
28139025
10.

Female genital schistosomiasis (FGS): from case reports to a call for concerted action against this neglected gynaecological disease.

Christinet V, Lazdins-Helds JK, Stothard JR, Reinhard-Rupp J.

Int J Parasitol. 2016 Jun;46(7):395-404. doi: 10.1016/j.ijpara.2016.02.006. Epub 2016 Apr 8. Review.

11.

Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemotherapy in patients with gemcitabine-refractory advanced pancreatic cancer: inflammation-based prognostic score predicts survival.

Kasuga A, Okano N, Naruge D, Kitamura H, Takasu A, Nagashima F, Furuse J.

Cancer Chemother Pharmacol. 2015 Mar;75(3):457-64. doi: 10.1007/s00280-014-2665-8. Epub 2014 Dec 30.

PMID:
25547407
12.

Eosinophil granule proteins ECP and EPX as markers for a potential early-stage inflammatory lesion in female genital schistosomiasis (FGS).

Ramarokoto CE, Kildemoes AO, Randrianasolo BS, Ravoniarimbinina P, Ravaoalimalala VE, Leutscher P, Kjetland EF, Vennervald BJ.

PLoS Negl Trop Dis. 2014 Jul 17;8(7):e2974. doi: 10.1371/journal.pntd.0002974. eCollection 2014 Jul.

13.

Balance control impairment induced after OKS in patients with vestibular migraine: an intercritical marker.

Panichi R, Cipriani L, Sarchielli P, Di Mauro M, Pettorossi V, Ricci G, Faralli M.

Eur Arch Otorhinolaryngol. 2015 Sep;272(9):2275-82.

PMID:
25015009
14.

Development of a patient-reported outcome measure of activity and participation (the OKS-APQ) to supplement the Oxford knee score.

Dawson J, Beard DJ, McKibbin H, Harris K, Jenkinson C, Price AJ.

Bone Joint J. 2014 Mar;96-B(3):332-8. doi: 10.1302/0301-620X.96B3.32845.

PMID:
24589787
15.

MED12 related disorders.

Graham JM Jr, Schwartz CE.

Am J Med Genet A. 2013 Nov;161A(11):2734-40. doi: 10.1002/ajmg.a.36183. Epub 2013 Oct 10. Review.

16.

Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients.

Morizane C, Okusaka T, Ueno H, Kondo S, Ikeda M, Furuse J, Shinichi O, Nakachi K, Mitsunaga S, Kojima Y, Suzuki E, Ueno M, Yamaguchi T.

Cancer Chemother Pharmacol. 2012 Apr;69(4):957-64. doi: 10.1007/s00280-011-1786-6. Epub 2011 Nov 26.

PMID:
22120961
17.

Facile fabrication of functionalized graphene sheets (FGS)/ZnO nanocomposites with photocatalytic property.

Yang Y, Ren L, Zhang C, Huang S, Liu T.

ACS Appl Mater Interfaces. 2011 Jul;3(7):2779-85. doi: 10.1021/am200561k. Epub 2011 Jul 6.

PMID:
21682271
18.

Cross-cultural adaptation and validation of the Portuguese version of the Oxford Knee Score (OKS).

Gonçalves RS, Tomás AM, Martins DI.

Knee. 2012 Aug;19(4):344-7. doi: 10.1016/j.knee.2011.04.006. Epub 2011 May 17.

PMID:
21592799
19.

The FG syndrome from a pathological perspective.

Neri C, Moser K, Pysher TJ, Boettger DR, Neri G, Opitz JM.

Fetal Pediatr Pathol. 2011;30(2):71-6. doi: 10.3109/15513815.2011.520259.

PMID:
21391746
20.

MED12-Related Disorders.

Lyons MJ.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A, Ledbetter N, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2008 Jun 23 [updated 2016 Aug 11].

Supplemental Content

Support Center